Tectonic Therapeutic, Inc. Common Stock TECX
i
Market datapartial · fetched 2026-11-08T09:15:41.586Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T22:53:20.042970641Z
FundamentalsAlpha Vantage · unavailable
Tectonic Therapeutic, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 15.83 | 371.7% | 40.1% | |||
| 25Δ | 17.90 | 297.8% | 30.9% | |||
| 30Δ | 19.46 | 250.6% | 24.0% | |||
| 35Δ | 20.69 | 223.4% | 19.4% | |||
| 40Δ | 23.47 | 116.6% | 12.1% | 21.73 | 206.7% | 16.1% |
| 45Δ | 23.14 | 128.7% | 12.0% | 22.82 | 196.5% | 13.2% |
| 50Δ | 22.81 | 140.8% | 11.8% | 24.04 | 204.6% | 11.8% |
| 55Δ | 22.49 | 151.9% | 11.6% | 25.56 | 217.5% | 10.6% |
| 60Δ | 22.11 | 137.2% | 10.0% | 28.26 | 249.3% | 10.0% |
| 65Δ | 21.74 | 122.5% | 8.3% | 32.16 | 293.0% | 9.5% |
| 70Δ | 21.36 | 107.8% | 6.7% | 38.47 | 344.9% | 8.7% |
| 75Δ | 20.99 | 93.1% | 5.0% | |||
| 80Δ | 20.61 | 78.4% | 3.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 15.83
- IV
- 371.7%
- B/E move
- 40.1%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 17.90
- IV
- 297.8%
- B/E move
- 30.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 19.46
- IV
- 250.6%
- B/E move
- 24.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 20.69
- IV
- 223.4%
- B/E move
- 19.4%
40Δ
- Pseudo strike
- 23.47
- IV
- 116.6%
- B/E move
- 12.1%
- Pseudo strike
- 21.73
- IV
- 206.7%
- B/E move
- 16.1%
45Δ
- Pseudo strike
- 23.14
- IV
- 128.7%
- B/E move
- 12.0%
- Pseudo strike
- 22.82
- IV
- 196.5%
- B/E move
- 13.2%
50Δ
- Pseudo strike
- 22.81
- IV
- 140.8%
- B/E move
- 11.8%
- Pseudo strike
- 24.04
- IV
- 204.6%
- B/E move
- 11.8%
55Δ
- Pseudo strike
- 22.49
- IV
- 151.9%
- B/E move
- 11.6%
- Pseudo strike
- 25.56
- IV
- 217.5%
- B/E move
- 10.6%
60Δ
- Pseudo strike
- 22.11
- IV
- 137.2%
- B/E move
- 10.0%
- Pseudo strike
- 28.26
- IV
- 249.3%
- B/E move
- 10.0%
65Δ
- Pseudo strike
- 21.74
- IV
- 122.5%
- B/E move
- 8.3%
- Pseudo strike
- 32.16
- IV
- 293.0%
- B/E move
- 9.5%
70Δ
- Pseudo strike
- 21.36
- IV
- 107.8%
- B/E move
- 6.7%
- Pseudo strike
- 38.47
- IV
- 344.9%
- B/E move
- 8.7%
75Δ
- Pseudo strike
- 20.99
- IV
- 93.1%
- B/E move
- 5.0%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 20.61
- IV
- 78.4%
- B/E move
- 3.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 132.52% | |
| 134.73% | |
| 131.16% | |
| 133.39% | |
| 140.27% | |
| 139.85% | |
| 148.12% | |
| 144.71% | |
| 139.68% | |
| 137.16% |
Biotechnology
TENX
Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the…
More →TGTX
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and…
More →TNGX
Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation, specializing in synthetic lethality and targeted therapies.…
More →TNXP
Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey.
More →TNYA
Description unavailable
More →TRAX
First Tracks Biotherapeutics (Ticker: TRAX) is a forward-thinking biotechnology company focused on developing targeted therapeutics for chronic diseases, utilizing advanced…
More →